These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7916954)

  • 1. Do MHC antigens generate pathogenetic peptides?
    Baum H; Cunningham P
    Immunol Today; 1994 Aug; 15(8):388-9. PubMed ID: 7916954
    [No Abstract]   [Full Text] [Related]  

  • 2. Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes.
    Xu XJ; Gearon C; Stevens E; Vergani D; Baum H; Peakman M
    Diabetologia; 1999 May; 42(5):560-5. PubMed ID: 10333048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
    J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faulty major histocompatibility complex class I function linked to autoimmune diabetes.
    Faustman D
    Transplant Proc; 1992 Dec; 24(6):2874-6. PubMed ID: 1465979
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune diabetes mellitus--much progress, but many challenges.
    McDevitt HO; Unanue ER
    Adv Immunol; 2008; 100():1-12. PubMed ID: 19111161
    [No Abstract]   [Full Text] [Related]  

  • 6. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-DR53 molecules restrict glutamic acid decarboxylase peptide presentation to T cells of a Type I diabetes patient: specification of the trimolecular HLA-peptide/T-cell receptor complex.
    Huck C; Endl J; Walk T; Noessner E; Jung G; Wank R; Schendel DJ
    Diabetologia; 2001 Jan; 44(1):70-80. PubMed ID: 11206414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.
    Carrasco-Marin E; Shimizu J; Kanagawa O; Unanue ER
    J Immunol; 1996 Jan; 156(2):450-8. PubMed ID: 8543793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of immunodominant peptide determinants of IDDM-associated autoantigens in the NOD mouse.
    Zechel MA; Chaturvedi P; Singh B
    Res Immunol; 1997 Jun; 148(5):338-48. PubMed ID: 9352599
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
    Quartey-Papafio R; Lund T; Chandler P; Picard J; Ozegbe P; Day S; Hutchings PR; O'Reilly L; Kioussis D; Simpson E
    J Immunol; 1995 May; 154(10):5567-75. PubMed ID: 7730655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene.
    Ranheim EA; Tarbell KV; Krogsgaard M; Mallet-Designe V; Teyton L; McDevitt HO; Weissman IL
    Autoimmunity; 2004 Dec; 37(8):555-67. PubMed ID: 15763918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of Ii-Key/MHC class II epitope hybrids derived from proinsulin and GAD peptides by T cells in type 1 diabetes.
    Vadacca M; Valorani MG; von Hofe E; Kallinteris NL; Buzzetti R; Pozzilli P
    Horm Metab Res; 2011 Jun; 43(7):483-8. PubMed ID: 21512962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cross-reactivity of I-A(g7) and I-A(d) tetramers.
    Peng Y; Liu CP
    Chin Med J (Engl); 2002 Oct; 115(10):1579-81. PubMed ID: 12490116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MHC class II molecules in the pathogenesis and prevention of Type I diabetes.
    McDevitt H
    Adv Exp Med Biol; 2001; 490():59-66. PubMed ID: 11505975
    [No Abstract]   [Full Text] [Related]  

  • 16. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
    Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
    J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
    Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
    Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence similarity between beta-cell autoantigens.
    Rudy G; Brusic V; Harrison LC; Lew AM
    Immunol Today; 1995 Aug; 16(8):406-7. PubMed ID: 7546199
    [No Abstract]   [Full Text] [Related]  

  • 19. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.
    Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP
    J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.